Position in WGS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,899,340
-$28,141,243 QoQ
Shares Held
341,005
-11.4% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 83.66475564874415.ToString("F0")%
None 16.335244351255845.ToString("F0")%
Common Shares in WGS Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $8,226,619,826 across 24 Diagnostics & Research names. WGS ranks #19 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
14,774,524 | $2,801,249,746 | |
| 2 | NTRA |
Natera, Inc.
|
4,768,593 | $953,670,911 | |
| 3 | A |
Agilent Technologies, Inc.
|
7,256,433 | $827,088,230 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
1,478,251 | $726,604,711 | |
| 5 | ICLR |
Icon PLC
|
5,913,037 | $654,336,671 | |
| 6 | QGEN |
Qiagen N.V.
|
14,364,303 | $575,146,689 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
735,475 | $413,256,044 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,629,401 | $281,071,670 |
All Filings in WGS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,899,340 | 341,005 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $50,040,583 | 384,750 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $42,636,057 | 395,731 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $37,530,752 | 406,573 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $37,697,425 | 425,647 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,821,271 | 140,792 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||